Search PubMed⌕ Search

Biomedical subjects

J L Green

Publications and source records attributed to J L Green.

At least 73 records · Page 4Linked to original sources
PubMed1981

Role of the CO2 laser in chorioretino-iridocyclectomy.

Surgical extirpation of a uveal melanoma was performed by a sclerochorioretino iridocyclectomy using an externally focused CO2 laser. This was followed by a lens extraction and partial vitrectomy. The uveal melanoma proved to be of a mixed cell type. The minimal operative and postoperative hemorrhaging was attributed in part to the cauterizing cutting characteristics of the CO2 laser. Extensive coagulation necrosis produced by the CO2 laser precluded histopathologic evaluation of the resected tissue margin.

Aged↗
PubMed1979

Vascular opacification and leakage in X-linked (juvenile) retinoschisis.

A 22-year-old man had X-linked retinoschisis with extensive vascular sheathing in the posterior pole and dendritic opacified retinal vessels in the periphery. Detailed fluorescein angiographic studies were performed. In the far periphery areas of capillary nonperfusion were seen. Sluggish circulation was present in the majority of dendritic opacified vessels in the areas of schisis. Late staining of the disc and posterior arteries and veins was noted. Scattered intraretinal fluorescein leakage was present even in clinically nonschitic retina, which suggests that the vascular changes may precede the retinoschisis. The patient's half-brother also had X-linked retinoschisis, but the schisis and the vascular changes were much less prominent. Although the retinal vascular changes with X-linked retinoschisis are similar to those seen with the Favre-Goldmann syndrome, a differentiation of the two diseases can be made by family studies, the presence or absence of nyctalopia, examination of the macular areas, measurement of dark adaptation, and electroretinogram determinations.

Adult↗
PubMed1979

The use of cefaclor in the treatment of beta-haemolytic streptococcal throat infections in children.

Cefaclor was used as a therapeutic agent in beta-haemolytic streptococcal throat infections in children in 3 separate studies. Although the numbers of patients in these ongoing studies are too small for valid statistical analysis, cefaclor was found to be (1) an effective agent in a dose of 20 mg/kg/day, (2) as effective as phenoxymethyl penicillin at identical dosages, and (3) equally effective at doses administered twice daily or thrice daily. It was well accepted by the patients, had minimal side effects, and produced no adverse effects in the peripheral blood.

Adolescent↗